Document is current
Any future updates will be listed below
-
Authors
Laskou, Faidra
Westbury, Leo D.
Fuggle, Nicholas R.
Edwards, Mark H.
Cooper, Cyrus
Dennison, Elaine M.
-
Funding
Funding for this research was provided by:
NIHR BRC Southampton
- License Information
-
More Information
Article History
Received: 17 February 2022
Accepted: 26 April 2022
First Online: 19 May 2022
Declarations
:
: EMD declares consultancy and speaker fees from Pfizer, UCB, Viatris and Lilly. CC has received lecture fees and honoraria from Amgen, Danone, Eli Lilly, GSK, Kyowa Kirin, Medtronic, Merck, Nestlé, Novartis, Pfizer, Roche, Servier, Shire, Takeda and UCB outside of the submitted work. MHE declares conference and course attendance funding from Eli Lilly, other from UCB, other from Pfizer, other from Chugai, other from AbbVie and an unrestricted project grant from Servier. NRF declares travel bursaries from Pfizer and Eli Lilly. LDW and LF declare no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and /or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. All study participants provided written informed consent and Ethical approval was obtained from the Hertfordshire and Bedfordshire Local Research Ethics Committee.
: Informed consent was obtained from all participants included in the study.
